288
Views
52
CrossRef citations to date
0
Altmetric
Review

Discovery of prostate cancer biomarkers by microarray gene expression profiling

&
Pages 49-64 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhijun Wang, Jeffery Fan, Mandy Liu, Steven Yeung, Andy Chang, Moses SS Chow, Doreen Pon & Ying Huang. (2013) Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application. Expert Opinion on Investigational Drugs 22:12, pages 1613-1626.
Read now

Articles from other publishers (51)

Sarathkumar Edachery, Prakash Patil, Rajashekar Mohan, Bhuvanesh Aradhya, Jayaprakash Shetty, Shama Prasada Kabekkodu, Manas Kumar Santra, Sathisha Jayanna Gonchigar & Praveenkumar Shetty. (2022) Loss of miR-936 leads to acquisition of androgen-independent metastatic phenotype in prostate cancer. Scientific Reports 12:1.
Crossref
Aylin Del Moral-Morales, Juan Carlos González-Orozco, Ana María Hernández-Vega, Karina Hernández-Ortega, Karla Mariana Peña-Gutiérrez & Ignacio Camacho-Arroyo. (2022) EZH2 Mediates Proliferation, Migration, and Invasion Promoted by Estradiol in Human Glioblastoma Cells. Frontiers in Endocrinology 13.
Crossref
Vinoth-Kumar Lakshmanan, Shreesh Ojha & Young Do Jung. (2020) A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer. Computers in Biology and Medicine 126, pages 104020.
Crossref
Gang Qian & YueLan Wang. (2020) Serum Metabolomics of Early Postoperative Cognitive Dysfunction in Elderly Patients Using Liquid Chromatography and Q-TOF Mass Spectrometry. Oxidative Medicine and Cellular Longevity 2020, pages 1-11.
Crossref
Jaslin P. James, Laura Johnsen, Trine Møller & Boye Schnack Nielsen. 2020. In Situ Hybridization Protocols. In Situ Hybridization Protocols 99 110 .
Boye Schnack Nielsen & Kim Holmstrøm. 2019. Target Identification and Validation in Drug Discovery. Target Identification and Validation in Drug Discovery 271 286 .
Toluleke Oloruntobi Famuyiwa. (2017) Prostate Cancer Cells Produce Exosomes Modulating Metastasis to the Bones. Journal of Cancer Prevention & Current Research 8:2.
Crossref
A. Marije Hoogland, René Böttcher, Esther Verhoef, Guido Jenster & Geert J.L.H. van Leenders. (2016) Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer. Oncotarget 7:25, pages 37846-37856.
Crossref
Michał P. Świtnicki, Malene Juul, Tobias Madsen, Karina D. Sørensen & Jakob S. Pedersen. (2016) PINCAGE: probabilistic integration of cancer genomics data for perturbed gene identification and sample classification. Bioinformatics 32:9, pages 1353-1365.
Crossref
Yongjia Yin, Cheng Shen, Pan Xie, Zeneng Cheng & Qubo Zhu. (2016) Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis. The Breast 26, pages 1-10.
Crossref
Xiaoying Zhou, Guoping Ji, Xiquan Ke, Huiyuan Gu, Wujuan Jin & Guoxin Zhang. (2015) MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression. Digestive Diseases and Sciences 60:11, pages 3271-3282.
Crossref
Paul L. Nguyen, Heesun Shin, Kasra Yousefi, Darby J. Thompson, John Hornberger, Andrew S. Hyatt, Ketan K. Badani, Todd M. Morgan & Felix Y. Feng. (2015) Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists. Urology 86:1, pages 35-40.
Crossref
Ganna Androsova, Roland Krause, Georg Winterer & Reinhard Schneider. (2015) Biomarkers of postoperative delirium and cognitive dysfunction. Frontiers in Aging Neuroscience 7.
Crossref
Baoyong Sun, Fangxin Wang, Min Li & Mingshan Yang. (2015) Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis. Medical Oncology 32:5.
Crossref
Ketan K. Badani, Darby J. Thompson, Gordon Brown, Daniel Holmes, Naveen Kella, David Albala, Amar Singh, Christine Buerki, Elai Davicioni & John Hornberger. (2015) Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery. BJU International 115:3, pages 419-429.
Crossref
Yuri TolkachFlorian ImkampKonstantin GodinHendrik Van Poppel. (2015) Clinically relevant genetic characterization of prostate tumors: How close are we to the goal?. Korean Journal of Urology 56:2, pages 90.
Crossref
Bruno Jim Rocca, Alessandro Ginori, Aurora Barone, Calogera Calandra, Filippo Crivelli, Giulia De Falco, Sara Gazaneo, Sergio Tripodi, Gabriele Cevenini, Maria Teresa del Vecchio, Maria Raffaella Ambrosio & Piero Tosi. (2015) Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment-Related Changes. BioMed Research International 2015, pages 1-8.
Crossref
A Paziewska, M Dabrowska, K Goryca, A Antoniewicz, J Dobruch, M Mikula, D Jarosz, L Zapala, A Borowka & J Ostrowski. (2014) DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy. British Journal of Cancer 111:4, pages 781-789.
Crossref
Martin Hart, Elke Nolte, Sven Wach, Jaroslaw Szczyrba, Helge Taubert, Tilman T. Rau, Arndt Hartmann, Friedrich A. Grässer & Bernd Wullich. (2014) Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing. Molecular Cancer Research 12:2, pages 250-263.
Crossref
Ivan P Gorlov, Ji-Yeon Yang, Jinyoung Byun, Christopher Logothetis, Olga Y Gorlova, Kim-Anh Do & Christopher Amos. (2014) How to get the most from microarray data: advice from reverse genomics. BMC Genomics 15:1, pages 223.
Crossref
Medha Darshan, Qizhi Zheng, Helen L. Fedor, Nicolas Wyhs, Srinivasan Yegnasubramanian, Peng Lee, Jonathan Melamed, George J. Netto, Bruce J. Trock, Angelo M. De Marzo & Karen S. Sfanos. (2014) Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network. The Prostate 74:1, pages 61-69.
Crossref
R. Jeffrey Karnes, Eric J. Bergstralh, Elai Davicioni, Mercedeh Ghadessi, Christine Buerki, Anirban P. Mitra, Anamaria Crisan, Nicholas Erho, Ismael A. Vergara, Lucia L. Lam, Rachel Carlson, Darby J.S. Thompson, Zaid Haddad, Benedikt Zimmermann, Thomas Sierocinski, Timothy J. Triche, Thomas Kollmeyer, Karla V. Ballman, Peter C. Black, George G. Klee & Robert B. Jenkins. (2013) Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population. Journal of Urology 190:6, pages 2047-2053.
Crossref
Asha Thomas, Umesh Mahantshetty, Sadhana Kannan, Kedar Deodhar, Shyam K. Shrivastava, Chandan Kumar‐Sinha & Rita Mulherkar. (2013) Expression profiling of cervical cancers in I ndian women at different stages to identify gene signatures during progression of the disease . Cancer Medicine 2:6, pages 836-848.
Crossref
Xiaoping Liu, Jiguang Wang & Luonan Chen. (2013) Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. Cancer Letters 340:2, pages 270-276.
Crossref
Dogus Murat Altintas, Nathalie Allioli, Myriam Decaussin, Simon de Bernard, Alain Ruffion, Jacques Samarut & Virginie Vlaeminck-Guillem. (2013) Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer. PLoS ONE 8:6, pages e66278.
Crossref
Hideaki Miyake & Masato Fujisawa. (2013) Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches. International Journal of Urology 20:3, pages 301-311.
Crossref
François-Clément Bidard, Jean-Yves Pierga, Jean-Charles Soria & Jean Paul Thiery. (2013) Translating metastasis-related biomarkers to the clinic—progress and pitfalls. Nature Reviews Clinical Oncology 10:3, pages 169-179.
Crossref
Ming Su. (2013) Multiplexed detection of molecular biomarkers with phase-change nanoparticles. Nanomedicine 8:2, pages 253-263.
Crossref
Krassimira Todorova, Milcho Mincheff, Soren Hayrabedyan, Jana Mincheva, Diana Zasheva, Aleksandar Kuzmanov & Nelson Fernández. (2012) Fundamental Role of micro RNA s in Androgen‐Dependent Male Reproductive Biology and Prostate Cancerogenesis . American Journal of Reproductive Immunology 69:2, pages 100-104.
Crossref
Zehui Cao. 2013. Molecular Beacons. Molecular Beacons 139 152 .
Boye Schnack Nielsen & Kim Holmstrøm. 2013. Target Identification and Validation in Drug Discovery. Target Identification and Validation in Drug Discovery 353 365 .
Karina D. Sørensen, Marie S. Ostenfeld, Dennis K. Jeppesen, Helle Kristensen, Christa Haldrup & Torben F. Ørntoft. 2013. RNA Interference from Biology to Therapeutics. RNA Interference from Biology to Therapeutics 259 298 .
Hideaki Miyake, Atsushi Takenaka & Masato Fujisawa. 2013. Prostate Cancer: A Comprehensive Perspective. Prostate Cancer: A Comprehensive Perspective 181 187 .
Takashi Shima, Atsushi Mizokami, Toru Miyagi, Keiichi Kawai, Kouji Izumi, Misako Kumaki, Mitsuo Ofude, Jian Zhang, Evan T. Keller & Mikio Namiki. (2012) Down‐regulation of calcium/calmodulin‐dependent protein kinase kinase 2 by androgen deprivation induces castration‐resistant prostate cancer. The Prostate 72:16, pages 1789-1801.
Crossref
Nina Pettersen Hessvik, Santosh Phuyal, Andreas Brech, Kirsten Sandvig & Alicia Llorente. (2012) Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1819:11-12, pages 1154-1163.
Crossref
Fu-Yan Hu, Xing-Ming Zhao, Nelson L.S. Tang, Yan Zhang & Luonan Chen. (2012) Comparative analysis of protein-coding genes and long non-coding RNAs of prostate cancer between Caucasian and Chinese populations. Comparative analysis of protein-coding genes and long non-coding RNAs of prostate cancer between Caucasian and Chinese populations.
Karina D Sørensen. (2012) Research Highlights: The search for better prostate cancer biomarkers continues. Personalized Medicine 9:5, pages 471-474.
Crossref
Jorge D. Escandriolo Nackauzi, Ra?l H. Colla, Graciela R. Ravazzani, Mar?a I. Gaido, Patricia Bertolotto & Adriana B. Actis. (2011) Prostate-specific antigen: its relationship with alcohol intake and tobacco. Medical Oncology 29:2, pages 823-826.
Crossref
Steven M. Lucas & Elisabeth I. Heath. (2012) Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers. Prostate Cancer 2012, pages 1-9.
Crossref
J. H. Phan, C. F. Quo, C. Cheng & M. D. Wang. (2012) Multiscale Integration of -Omic, Imaging, and Clinical Data in Biomedical Informatics. IEEE Reviews in Biomedical Engineering 5, pages 74-87.
Crossref
Pornpimol Charoentong, Hubert Hackl, Bernhard Mlecnik, Gabriela Bindea, Jerome Galon & Zlatko Trajanoski. 2012. Computational Medicine. Computational Medicine 159 172 .
Margaret Barh, Debmalya Blum & Kenneth MadiganHiroaki Ohdaira & Kenichi Yoshida. 2011. OMICS. OMICS 359 378 .
Agnes Marije Hoogland, Anna Dahlman, Kees J. Vissers, Tineke Wolters, Fritz H. Schr?der, Monique J. Roobol, Anders S. Bjartell & Geert J.L.H. van Leenders. (2011) Cysteine-rich secretory protein 3 and ?-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome. BJU International 108:8, pages 1356-1362.
Crossref
Alix Bee, Daniel Brewer, Carol Beesley, Andrew Dodson, Shiva Forootan, Timothy Dickinson, Patricia Gerard, Brian Lane, Sheng Yao, Colin S. Cooper, Mustafa B. A. Djamgoz, Christine M. Gosden, Youqiang Ke & Christopher S. Foster. (2011) siRNA Knockdown of Ribosomal Protein Gene RPL19 Abrogates the Aggressive Phenotype of Human Prostate Cancer. PLoS ONE 6:7, pages e22672.
Crossref
Dara L Aisner & Dan Theodorescu. (2011) Genetic testing for metastasis: potential for improved cancer treatment. Future Oncology 7:6, pages 697-701.
Crossref
Michael J. Joyner & Bente K. Pedersen. (2011) Ten questions about systems biology. The Journal of Physiology 589:5, pages 1017-1030.
Crossref
Wei Li, Wu Di, Lijuan Hua, Bingrong Zhou, Ze Guo & Dan Luo. (2011) UVB suppresses PTEN expression by upregulating miR-141 in HaCaT cells. Journal of Biomedical Research 25:2, pages 135-140.
Crossref
Wolfgang A Schulz & Teodora Ribarska. (2011) Insights into cancer mechanisms from genomic research on urological cancers. Genome Medicine 3:3, pages 20.
Crossref
Ghada Naji, Mohamad Nagi, Abdallah M. ElSheikh, Shang Gao, Keivan Kianmehr, Tansel Özyer, Jon Rokne, Douglas Demetrick, Mick Ridley & Reda Alhajj. 2011. Counterterrorism and Open Source Intelligence. Counterterrorism and Open Source Intelligence 285 313 .
Takuji Tanaka, Mayu Tanaka, Takahiro Tanaka & Rikako Ishigamori. (2010) Biomarkers for Colorectal Cancer. International Journal of Molecular Sciences 11:9, pages 3209-3225.
Crossref
XuPing Fu, ChenYi Xue, Yan Huang, Yi Xie & Yao Li. (2010) The activity and expression of microRNAs in prostate cancers. Molecular BioSystems 6:12, pages 2561.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.